Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

ASK1 signalling regulates brown and beige adipocyte function

Hattori K., Naguro I., Okabe K., Funatsu T., Furutani S., Takeda K.

Animal Study, published in Nat Commun (2016) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Nat Commun (2016)
Reported sample size
—
Source database
Europe PMC
PMID
27045525
PMCID
PMC4822029
DOI
10.1038/ncomms11158
Citations
56

Abstract (original English)

Recent studies suggest that adult humans have active brown or beige adipocytes, the activation of which might be a therapeutic strategy for the treatment of diverse metabolic diseases. Here we show that the protein kinase ASK1 regulates brown and beige adipocytes function. In brown or white adipocytes, the PKA-ASK1-p38 axis is activated in response to cAMP signalling and contributes to the cell-autonomous induction of genes, including Ucp1. Global and fat-specific ASK1 deficiency leads to impaired metabolic responses, including thermogenesis and oxygen consumption, at the cell and whole-body levels, respectively. Our data thus indicate that the ASK1 signalling axis is a regulator of brown and beige adipocyte gene expression and function.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
3T3-L1 CellsAnimalsMice, Inbred C57BLHumansMiceCyclic AMP-Dependent Protein KinasesMAP Kinase Kinase Kinase 5p38 Mitogen-Activated Protein KinasesIon ChannelsMitochondrial Proteins

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.